Cart
sales@molnova.com
Loperamide hydrochloride
CAS No. 34552-83-5
Loperamide hydrochloride( NSC 696356 | PJ 185 | R 18553 )
Catalog No. M14181 CAS No. 34552-83-5
Loperamide HCl is an opioid-receptor agonist used as long-acting synthetic antidiarrheals.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | 45 | In Stock |
|
| 500MG | 69 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLoperamide hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionLoperamide HCl is an opioid-receptor agonist used as long-acting synthetic antidiarrheals.
-
DescriptionLoperamide HCl is an opioid-receptor agonist used as long-acting synthetic antidiarrheals.
-
In Vitro——
-
In Vivo——
-
SynonymsNSC 696356 | PJ 185 | R 18553
-
PathwayEndocrinology/Hormones
-
TargetOpioid Receptor
-
Recptorδ-opioid receptor| κ-opioid receptor| κ-opioid receptor| μ-opioid receptor
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number34552-83-5
-
Formula Weight513.51
-
Molecular FormulaC29H34Cl2N2O2
-
Purity>98% (HPLC)
-
SolubilityEthanol: 4 mg/mL (7.78 mM); DMSO: 22 mg/mL (42.84 mM)
-
SMILESO=C(N(C)C)C(C1=CC=CC=C1)(C2=CC=CC=C2)CCN3CCC(O)(C4=CC=C(Cl)C=C4)CC3.[H]Cl
-
Chemical Name1-Piperidinebutanamide, 4-(4-chlorophenyl)-4-hydroxy-N,N-dimethyl-alpha,alpha-diphenyl-, hydrochloride
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.DeHaven-Hudkins DL, et al. J Pharmacol Exp Ther. 1999 Apr;289(1):494-502.
molnova catalog
related products
-
FDI-6
FDI-6 is an effective and selective inhibitor of FOXM1 that blocks DNA binding. FDI-6 binds to the FOXM1 protein and specifically downregulates FOXM1-activated genes.
-
CP-866087
CP-866087 is a novel, potent and selective mu-opioid receptor antagonist for the study of female sexual dysfunction.
-
UFP-101
Potent, selective and competitive silent antagonist for the NOP opioid receptor. Binds to NOP with high affinity (pKi = 10.24) and displays > 3000-fold selectivity over δ, μ and κ opioid receptors. Antinociceptive and opposes the action of nociceptin in vivo.
